NYSE:IBM 3 January 2026 - 18 January 2026

New York, January 13, 2026, 21:08 ET — Markets have shut down for the day. Confluent confirmed that the U.S. antitrust waiting period for International Business Machines’ $11 billion acquisition has lapsed, marking a key regulatory milestone. The Hart-Scott-Rodino Act’s waiting period expired at 11:59 p.m. ET on Jan. 12. IBM shares closed Tuesday down 2.9% at $303.16. Confluent also announced a shareholder meeting scheduled for Feb. 12 but noted that additional regulatory approvals remain pending.

Confluent said on Monday it will report fourth-quarter and full-year 2025 results on Feb. 11, but it will not hold an earnings conference call or provide a financial outlook because of its pending sale to IBM. https://www.businesswire.com/news/home/20260112152645/en/Confluent-to-Announce-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-on-February-11-2026 That matters now because earnings calls are usually where management answers the only question deal traders keep asking: is anything slowing down. With no call, the stock loses one of its few near-term pressure points.

NEW YORK, Jan 3, 2026, 15:58 ET — Market closed Confluent shares slipped 0.4% to $30.11 at Friday’s close, after trading between $30.09 and $30.30. Volume was about 29.4 million shares.

New York, Jan 2, 2026, 20:47 ET — Market closed Confluent, Inc. shares closed down 0.4% at $30.11 on Friday, ending the first trading day of 2026 just under IBM’s $31-per-share cash offer. IBM has said the all-cash acquisition values Confluent at an enterprise value of $11 billion, is expected to close by mid-2026, and has support agreements from investors controlling about 62% of Confluent’s voting power. Yahoo Finance